Pharmacogenomic testing can tell how a drug is likely to work in a certain person. But is it ready for rolling out to the wider population?
Articles on Pharmacogenomics
Displaying all articles
Genetic testing can help take the guesswork out of finding the right treatment. For certain diseases. To an extent.
Up to 50% of the people who take the efavirenz antiretroviral react particularly badly to it and need to change drug regimens.
Why does the same medication, at the same dose, work well for some people, but not for others? The answer is in our genes.
How someone suffering from schizophrenia responds to treatment and manages their disorder is dependent on errors in their genes, according to new research.
Hidden among all the other announcements in last week’s State of the Union address by US President Barack Obama was a promise to fund a new “precision medicine initiative”. The president said it would…
Although in use for over 50 years now, chemotherapy is a blunt instrument in the battle against cancer and one that’s based on an outdated understanding of tumour biology. Personalised treatment has been…
Pharmacogenomics is the study of drugs (pharmakon- the Greek word for poison or drug) and the genome. These two come together to explain why about 50% of medicines don’t work in some people and why they…
Top contributors
-
Dean of the College of Pharmacy, Distinguished Professor of Pharmacy and Medicine, and Director of UF Health Personalized Medicine Program, University of Florida
-
Honorary Fellow, Department of Pathology, The University of Melbourne
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Professor of Genetics and Executive Director of Research, Melbourne Health
-
Professor- Clinical & Experimental Pharmacology, Adelaide University
-
Honorary Prof. of Clinical Pharmacology,, University of Cape Town
-
Lecturer and Researcher, Department of Genetics; & SU/ UCT MRC Unit on Risk and Resilience in Mental Disorders, Stellenbosch University
-
Associate Professor of Pharmacy and Therapeutics, University of Pittsburgh
-
Fellow in Clinical Pharmacogenomics, University of Pittsburgh
-
Associate Professor, Pharmacy and Therapeutics; Director, Pharmacogenomics Center of Excellence, University of Pittsburgh
-
Ethical, Legal & Social Adviser in Public Health Genomics, Monash University